Skip to content

Author

I. Alhaddad

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

The role of ranolazine in managing chronic coronary syndrome: a synthesis of clinical outcomes and health economic modelling

Patients with chronic coronary syndrome (CCS) frequently experience ongoing angina, diminished quality of life (QoL), and face a heightened need for revascularisation procedures. The present analysis aimed to consolidate clinical and health economic data regarding the use of ranolazine in CCS. By combining...

P. Collins, W. Alhabeeb, I. Alhaddad et al. · 0 citations
Review Open access Aug 2026

Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application

Valvular heart disease encompasses a diverse group of hemodynamic disorders that are frequently associated with heart failure, recurrent hospitalizations, and substantial morbidity despite advances in transcatheter and surgical therapies. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as a cornerstone o...

H. Allaham, C. M. Gibson, A. Finn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.